Solventum Corporation (SOLV)
(Delayed Data from NYSE)
$73.68 USD
+1.27 (1.75%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $73.71 +0.03 (0.04%) 7:40 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Price, Consensus and EPS Surprise
SOLV 73.68 +1.27(1.75%)
Will SOLV be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SOLV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SOLV
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
SOLV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus
Other News for SOLV
Solventum commits to 100% renewable electricity by 2030
Solventum Reaches Analyst Target Price
Solventum appoints Ryan Egeland as CMO
Solventum appoints Ryan Egeland as Chief Medical Officer
Buy 4 October Dividend Aristocrats & Watch 10